Transport of valproate at intestinal epithelial (Caco-2) and brain endothelial (RBE4) cells: Mechanism and substrate specificity
Transport of valproate at intestinal epithelial (Caco-2) and brain endothelial (RBE4) cells: Mechanism and substrate specificity
复制标题
DOI:
10.1016/j.ejpb.2008.05.022
复制
发表时间:
2008-10-01
影响因子:
4.9
通讯作者:
Brandsch, Matthias
中科院分区:
文献类型:
--
作者:
Fischer, Wiebke;Praetor, Katrin;Brandsch, Matthias
To reach its target cells, the antiepileptic drug valproate has to cross both the intestinal epithelial barrier and the blood-brain barrier in intact form as well as in sufficient amounts. This study was performed to characterize the epithelial transport of valproate at intestinal (Caco-2) and at blood-brain barrier (RBE4) cells. At both cell types, uptake of [H-3]valproate was independent of inwardly directed Na+, Ca2+, Mg2+, K+ or Cl- gradients. Uptake was, however, strongly stimulated by an inwardly directed H+ gradient. The cells accumulated valproate against a concentration gradient and the uptake rate of valproate was saturable with K-t values of 0.6 and 0.8 mM. At Caco-2 cell monolayers, the total apical-to-basolateral flux of [H-3]valproate exceeded the basolateral-to-apical flux 14-fold. Various monocarboxylic acids like salicylate, benzoate, acetate, propionate, butyrate, hexanoate, diclofenac and ibuprofen inhibited [H-3]valproate uptake at both cell types. Lactate and pyruvate inhibited valproate uptake at RBE4 cells but not at Caco-2 cells. We conclude that valproate is accumulated in intestinal cells against a concentration gradient by the activity of a specific H+-dependent DIDS-insensitive transport system for monocarboxylates not identical with monocarboxylate transporter 1 (MCTI). The passage of valproate across the blood-brain barrier is very likely mediated by MCTI. (C) 2008 Elsevier B.V. All rights reserved.